NCT06173232招募中不适用
Assessment of Retinal Fundus Imaging Camera
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Primary Objective
研究概览
简要总结
The goal of this prospective study is to evaluate device performance when using fundus images taken from retinal fundus cameras in subjects with and without diabetic retinopathy per ETDRS level 35 and higher with or without macular edema.
详细描述
The goal of this prospective study is to evaluate device performance when using fundus images taken from retinal fundus cameras in subjects with and without diabetic retinopathy (ETDRS level 35 and higher) with or without macular edema. Study subjects will sign the informed consent form, and data collection will involve being imaged by cameras.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 22 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •22 years of age or older.
- •Documented diagnosis of diabetes mellitus, as per any of the following: Having met the criteria established by the World Health Organization (WHO) and/or the American Diabetes Association (ADA), Hemoglobin A1c (HbA1c) ≥ 6.5%, Fasting Plasma Glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L), Oral Glucose Tolerance Test (OGTT) with two-hour plasma glucose (2-hr PG) ≥ 200 mg/dL (11.1 mmol/L), using the equivalent of an oral 75g anhydrous glucose dose dissolved in water, Symptoms of hyperglycemia or hyperglycemic crisis with a random plasma glucose (RPG) ≥ 200 mg/dL (11.1 mmol/L)
- •Ability to understand and the willingness to sign a written informed consent document.
- •Diagnosis from a retinal specialist of ETDRS level of 35 or higher with or without DME or diagnosis from a retinal specialist of ETDRS level 20 or lower and no DME.
- •Standard Corrected Visual Acuity of at least 20/40 or better in both eyes.
排除标准
- •Currently participating in an interventional eye study (e.g., actively receiving the investigational product for Diabetic Retinopathy (DR) and/or Diabetic Macular Edema (DME)).
- •Has a condition that, in the opinion of the investigator, would preclude participation in the study (e.g., unstable medical status including blood pressure or glycemic control, microphthalmia, or previous enucleation).
- •Pregnancy
- •Has a known allergy to or contraindication for the use of Tropicamide 1% or other mydriatic eye drops.
- •Any condition that is contraindicated for the use of study devices in the opinion of the investigator.
- •Contraindication for imaging by devices used in the study due to any of the following:
- •Subject is hypersensitive to light
- •Subject recently underwent photodynamic therapy (PDT)
- •Subject is taking medication that causes photosensitivity
结局指标
主要结局
Primary Objective
时间窗: 1 Day
Agreement of AI device results (mtmDR(+), mtmDR(-)) obtained from fundus cameras
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2Cystic Fibrosis-related DiabetesType 2 DiabetesType 1 DiabetesNCT05463289Johns Hopkins University500
尚未招募
Unknown
Role of Artificial Intelligence for Glaucoma screening in patients visiting a general ophthalmology clinicCTRI/2024/06/069657Remidio Innovative Solutions Inc
已完成
不适用
Fundus Image-guided Focal Electroretinography, Usability StudyHealthyMacular EdemaMacular DegenerationNCT05100511Maculaser Oy20
已完成
不适用
Digital Ocular Fundus Photography in the Emergency Department: A New Application for Telemedicine?HeadacheAcute, Focal Neurologic DiseaseSeverely Elevated Blood PressureAcute Visual LossNCT00873613Emory University705
Unknown
不适用
Artificial Intelligence System for Assessing Image Quality of Fundus Images and Its Effects on DiagnosisRetinal DiseasesArtificial IntelligenceNCT04289064Sun Yat-sen University300